Crowley Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Crowley Wealth Management's ARKG Position: Q4 2025 in Review
Crowley Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 600 shares — an estimated $16.7K sold.
Crowley Wealth Management first reported a position in ARKG in Q4 2024 and held it in 4 quarters. The position peaked at $16.7K in Q3 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- Crowley Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- Crowley Wealth Management sold 600 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $16.7K.
- Crowley Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 4 quarters.
- Crowley Wealth Management's ARK Genomic Revolution ETF position peaked at $16.7K in Q3 2025.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on Crowley Wealth Management's 13F filing for Q4 2025.